Content area

Abstract

Aging involves the systemic deterioration of all known cell types in most eukaryotes. Several recently discovered compounds that extend the healthspan and lifespan of model organisms decelerate pathways that govern the aging process. Among these geroprotectors, spermidine, a natural polyamine ubiquitously found in organisms from all kingdoms, prolongs the lifespan of fungi, nematodes, insects and rodents. In mice, it also postpones the manifestation of various age-associated disorders such as cardiovascular disease and neurodegeneration. The specific features of spermidine, including its presence in common food items, make it an interesting candidate for translational aging research. Here, we review novel insights into the geroprotective mode of action of spermidine at the molecular level, as we discuss strategies for elucidating its clinical potential.

Spermidine is a naturally occurring polyamine that elicits geroprotection and autophagy induction across species. This Review delineates its molecular targets, effects on the hallmarks of aging, and recent insights from epidemiological and clinical studies.

Details

Title
Mechanisms of spermidine-induced autophagy and geroprotection
Author
Hofer, Sebastian J. 1   VIAFID ORCID Logo  ; Simon, Anna Katharina 2 ; Bergmann, Martina 3 ; Eisenberg, Tobias 4   VIAFID ORCID Logo  ; Kroemer, Guido 5   VIAFID ORCID Logo  ; Madeo, Frank 4   VIAFID ORCID Logo 

 Institute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, Austria (GRID: grid.5110.5) (ISNI: 0000000121539003); Field of Excellence BioHealth, University of Graz, Graz, Austria (GRID: grid.5110.5) (ISNI: 0000000121539003); BioTechMed Graz, Graz, Austria (GRID: grid.452216.6); Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France (GRID: grid.417925.c); Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France (GRID: grid.14925.3b) (ISNI: 0000 0001 2284 9388) 
 Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK (GRID: grid.4991.5) (ISNI: 0000 0004 1936 8948); Max Delbrück Center, Berlin, Germany (GRID: grid.419491.0) (ISNI: 0000 0001 1014 0849) 
 Institute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, Austria (GRID: grid.5110.5) (ISNI: 0000000121539003) 
 Institute of Molecular Biosciences, NAWI Graz, University of Graz, Graz, Austria (GRID: grid.5110.5) (ISNI: 0000000121539003); Field of Excellence BioHealth, University of Graz, Graz, Austria (GRID: grid.5110.5) (ISNI: 0000000121539003); BioTechMed Graz, Graz, Austria (GRID: grid.452216.6) 
 Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France (GRID: grid.417925.c); Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France (GRID: grid.14925.3b) (ISNI: 0000 0001 2284 9388); Institut du Cancer Paris CARPEM, Department of Biology, Hôpital Européen Georges Pompidou, AP-HP, Paris, France (GRID: grid.414093.b) (ISNI: 0000 0001 2183 5849) 
Pages
1112-1129
Section
Review Article
Publication year
2022
Publication date
Dec 2022
Publisher
Nature Publishing Group
e-ISSN
26628465
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3102044688
Copyright
© Springer Nature America, Inc. 2022